vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and KILROY REALTY CORP (KRC). Click either name above to swap in a different company.
KILROY REALTY CORP is the larger business by last-quarter revenue ($272.2M vs $270.7M, roughly 1.0× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 6.3%, a 8.6% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs -5.0%). KILROY REALTY CORP produced more free cash flow last quarter ($450.3M vs $33.8M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -1.2%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.
BCPC vs KRC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $272.2M |
| Net Profit | $40.3M | $17.1M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | — |
| Net Margin | 14.9% | 6.3% |
| Revenue YoY | 8.1% | -5.0% |
| Net Profit YoY | 8.7% | -73.7% |
| EPS (diluted) | $1.25 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $272.2M | ||
| Q3 25 | $267.6M | $279.7M | ||
| Q2 25 | $255.5M | $289.9M | ||
| Q1 25 | $250.5M | $270.8M | ||
| Q4 24 | $240.0M | $286.4M | ||
| Q3 24 | $239.9M | $289.9M | ||
| Q2 24 | $234.1M | $280.7M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $17.1M | ||
| Q3 25 | $40.3M | $162.3M | ||
| Q2 25 | $38.3M | $79.6M | ||
| Q1 25 | $37.1M | $43.7M | ||
| Q4 24 | $33.6M | $65.0M | ||
| Q3 24 | $33.8M | $57.7M | ||
| Q2 24 | $32.1M | $54.5M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 19.6% | — |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 6.3% | ||
| Q3 25 | 15.1% | 58.0% | ||
| Q2 25 | 15.0% | 27.4% | ||
| Q1 25 | 14.8% | 16.1% | ||
| Q4 24 | 14.0% | 22.7% | ||
| Q3 24 | 14.1% | 19.9% | ||
| Q2 24 | 13.7% | 19.4% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.11 | ||
| Q3 25 | $1.24 | $1.31 | ||
| Q2 25 | $1.17 | $0.57 | ||
| Q1 25 | $1.13 | $0.33 | ||
| Q4 24 | $1.03 | $0.50 | ||
| Q3 24 | $1.03 | $0.44 | ||
| Q2 24 | $0.98 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $179.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $5.4B |
| Total Assets | $1.7B | $10.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $179.3M | ||
| Q3 25 | $65.1M | $372.4M | ||
| Q2 25 | $65.4M | $193.1M | ||
| Q1 25 | $49.9M | $146.7M | ||
| Q4 24 | $49.5M | $165.7M | ||
| Q3 24 | $73.7M | $625.4M | ||
| Q2 24 | $63.7M | $835.9M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $5.4B | ||
| Q3 25 | $1.3B | $5.5B | ||
| Q2 25 | $1.3B | $5.4B | ||
| Q1 25 | $1.2B | $5.4B | ||
| Q4 24 | $1.1B | $5.4B | ||
| Q3 24 | $1.2B | $5.4B | ||
| Q2 24 | $1.1B | $5.4B |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $10.9B | ||
| Q3 25 | $1.7B | $11.0B | ||
| Q2 25 | $1.7B | $10.9B | ||
| Q1 25 | $1.6B | $10.9B | ||
| Q4 24 | $1.6B | $10.9B | ||
| Q3 24 | $1.6B | $11.4B | ||
| Q2 24 | $1.6B | $11.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $566.3M |
| Free Cash FlowOCF − Capex | $33.8M | $450.3M |
| FCF MarginFCF / Revenue | 12.5% | 165.4% |
| Capex IntensityCapex / Revenue | 2.3% | 42.6% |
| Cash ConversionOCF / Net Profit | 0.99× | 33.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $833.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $566.3M | ||
| Q3 25 | $65.6M | $176.6M | ||
| Q2 25 | $47.3M | $143.7M | ||
| Q1 25 | $36.5M | $136.9M | ||
| Q4 24 | $52.3M | $541.1M | ||
| Q3 24 | $51.3M | $176.3M | ||
| Q2 24 | $45.0M | $88.7M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $450.3M | ||
| Q3 25 | — | $148.7M | ||
| Q2 25 | — | $118.4M | ||
| Q1 25 | — | $115.6M | ||
| Q4 24 | — | $440.8M | ||
| Q3 24 | — | $147.2M | ||
| Q2 24 | — | $69.5M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 165.4% | ||
| Q3 25 | — | 53.1% | ||
| Q2 25 | — | 40.9% | ||
| Q1 25 | — | 42.7% | ||
| Q4 24 | — | 153.9% | ||
| Q3 24 | — | 50.8% | ||
| Q2 24 | — | 24.7% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 42.6% | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 35.0% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | 6.8% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 33.10× | ||
| Q3 25 | 1.63× | 1.09× | ||
| Q2 25 | 1.23× | 1.81× | ||
| Q1 25 | 0.98× | 3.13× | ||
| Q4 24 | 1.56× | 8.32× | ||
| Q3 24 | 1.52× | 3.06× | ||
| Q2 24 | 1.40× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
